PharmaCorp Rx

Canaccord Genuity Acted as Lead-Left Bookrunner to PharmaCorp Rx Inc. on its Upsized Public Offering

On November 12, 2025, PharmaCorp Rx Inc. (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform, closed its upsized underwritten public offering for gross proceeds of C$23 million. Canaccord Genuity acted as Lead-Left Bookrunner for the offering.

Through a combination of capital, strategic support, and operational expertise, PharmaCorp is building a national network of community pharmacies under the PharmaChoice Canada banner. PharmaCorp currently operates seven PharmaChoice Canada bannered pharmacies and will continue to acquire both PharmaChoice Canada bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform in accordance with its strategic alliance with PharmaChoice Canada.